Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 20 December, 2018

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 1926L
GlaxoSmithKline PLC
20 December 2018
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr R Simard

b)

Position/status

President, Pharma Supply Chain

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

 

 

 

b)

Nature of the transaction

Cash payout of £47,832.11 less applicable tax withholding in respect of 3,231.899 notional Ordinary Shares following vesting of an award made on 16 December 2013 under the GlaxoSmithKline Deferred Investment Award plan.

c)

Price(s) and volume(s)


Price(s)

Volume(s)



 £14.8000

 

 3231.899






d)

Aggregated information

n/a (single transaction)

Aggregated volume Price


e)

Date of the transaction

2018-12-17

f)

Place of the transaction

 

n/a

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHDBLFLVLFFFBZ

a d v e r t i s e m e n t